Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (1-10 of 258) with videos related to

Pageof 26
Sort By:
Cancer Research|September 23, 2010
PALB2/FANCN: recombining cancer and Fanconi anemiaMarc Tischkowitz, Bing Xia
Journal of Genetic Counseling|August 7, 2017
When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling ChallengesBeverley Speight, Marc Tischkowitz
British Journal of Haematology|July 9, 2004
Fanconi anaemia and leukaemia - clinical and molecular aspectsMarc Tischkowitz, Inderjeet Dokal
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
Inherited cancer in children: practical/ethical problems and challengesMarc Tischkowitz, Elisabeth Rosser
Best Practice & Research. Clinical Obstetrics & Gynaecology|February 17, 2017
Genetics of gynaecological cancersPanayiotis Constantinou, Marc Tischkowitz
The Journal of Pathology|May 11, 2011
Using mouse models to investigate the biological and physiological consequences of defects in the Fanconi anaemia/breast cancer DNA repair signalling pathwayMarc Tischkowitz, Robert Winqvist
Breast Cancer Research and Treatment|October 18, 2017
Clinical implications of germline mutations in breast cancer: TP53Katherine Schon, Marc Tischkowitz
Breast Cancer Research and Treatment|January 6, 2019
Clinical implications of germline mutations in breast cancer genes: RECQLA Ramsay Bowden, Marc Tischkowitz
Clinical Medicine (London, England)|December 3, 2017
The use of panel testing in familial breast and ovarian cancerMatina Prapa, Joyce Solomons, Marc Tischkowitz
Science Translational Medicine|December 3, 2011
miRNA processing and human cancer: DICER1 cuts the mustardAmin Bahubeshi, Marc Tischkowitz, William D Foulkes
Pageof 26

Showing results (1-10 of 258) with videos related to

Sort By:
Pageof 26
Cancer Research|September 23, 2010
PALB2/FANCN: recombining cancer and Fanconi anemiaMarc Tischkowitz, Bing Xia
Journal of Genetic Counseling|August 7, 2017
When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling ChallengesBeverley Speight, Marc Tischkowitz
British Journal of Haematology|July 9, 2004
Fanconi anaemia and leukaemia - clinical and molecular aspectsMarc Tischkowitz, Inderjeet Dokal
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
Inherited cancer in children: practical/ethical problems and challengesMarc Tischkowitz, Elisabeth Rosser
Best Practice & Research. Clinical Obstetrics & Gynaecology|February 17, 2017
Genetics of gynaecological cancersPanayiotis Constantinou, Marc Tischkowitz
The Journal of Pathology|May 11, 2011
Using mouse models to investigate the biological and physiological consequences of defects in the Fanconi anaemia/breast cancer DNA repair signalling pathwayMarc Tischkowitz, Robert Winqvist
Breast Cancer Research and Treatment|October 18, 2017
Clinical implications of germline mutations in breast cancer: TP53Katherine Schon, Marc Tischkowitz
Breast Cancer Research and Treatment|January 6, 2019
Clinical implications of germline mutations in breast cancer genes: RECQLA Ramsay Bowden, Marc Tischkowitz
Clinical Medicine (London, England)|December 3, 2017
The use of panel testing in familial breast and ovarian cancerMatina Prapa, Joyce Solomons, Marc Tischkowitz
Science Translational Medicine|December 3, 2011
miRNA processing and human cancer: DICER1 cuts the mustardAmin Bahubeshi, Marc Tischkowitz, William D Foulkes
Pageof 26